Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.72295810 |
2 | vocalization behavior (GO:0071625) | 5.67018220 |
3 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.66464825 |
4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.57768026 |
5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.56735915 |
6 | locomotory exploration behavior (GO:0035641) | 5.38773494 |
7 | protein localization to synapse (GO:0035418) | 5.33553635 |
8 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.19633598 |
9 | synaptic vesicle exocytosis (GO:0016079) | 5.19175362 |
10 | glutamate receptor signaling pathway (GO:0007215) | 5.18847212 |
11 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.15793280 |
12 | exploration behavior (GO:0035640) | 4.99793126 |
13 | neuron cell-cell adhesion (GO:0007158) | 4.89166480 |
14 | synaptic vesicle maturation (GO:0016188) | 4.85527899 |
15 | glutamate secretion (GO:0014047) | 4.82045698 |
16 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.76959050 |
17 | synaptic transmission, glutamatergic (GO:0035249) | 4.65809671 |
18 | L-amino acid import (GO:0043092) | 4.65456510 |
19 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.56080021 |
20 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.54342437 |
21 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.53727126 |
22 | neuron recognition (GO:0008038) | 4.48496141 |
23 | neuron-neuron synaptic transmission (GO:0007270) | 4.37430889 |
24 | positive regulation of synapse maturation (GO:0090129) | 4.31089158 |
25 | amino acid import (GO:0043090) | 4.28085487 |
26 | regulation of synaptic vesicle transport (GO:1902803) | 4.23123977 |
27 | dendritic spine morphogenesis (GO:0060997) | 4.21983977 |
28 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.21228337 |
29 | neuronal action potential propagation (GO:0019227) | 4.18505006 |
30 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.16548408 |
31 | layer formation in cerebral cortex (GO:0021819) | 4.08362788 |
32 | long-term memory (GO:0007616) | 4.08227831 |
33 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.02947434 |
34 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.02374484 |
35 | axonal fasciculation (GO:0007413) | 4.00916600 |
36 | regulation of synapse structural plasticity (GO:0051823) | 3.99861129 |
37 | regulation of synaptic plasticity (GO:0048167) | 3.95251371 |
38 | regulation of postsynaptic membrane potential (GO:0060078) | 3.94849428 |
39 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.91704256 |
40 | long-term synaptic potentiation (GO:0060291) | 3.91186447 |
41 | synaptic vesicle endocytosis (GO:0048488) | 3.90327060 |
42 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.89590055 |
43 | proline transport (GO:0015824) | 3.86610714 |
44 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.84877340 |
45 | neurotransmitter secretion (GO:0007269) | 3.79649430 |
46 | positive regulation of membrane potential (GO:0045838) | 3.75958842 |
47 | primary amino compound metabolic process (GO:1901160) | 3.72496551 |
48 | response to histamine (GO:0034776) | 3.69561137 |
49 | dendritic spine organization (GO:0097061) | 3.68720311 |
50 | * gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.66643569 |
51 | postsynaptic membrane organization (GO:0001941) | 3.66151446 |
52 | transmission of nerve impulse (GO:0019226) | 3.65481324 |
53 | cellular potassium ion homeostasis (GO:0030007) | 3.62211763 |
54 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.62023012 |
55 | positive regulation of dendritic spine development (GO:0060999) | 3.60214234 |
56 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.60015458 |
57 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.57253261 |
58 | neuronal ion channel clustering (GO:0045161) | 3.54737128 |
59 | * behavioral defense response (GO:0002209) | 3.50543017 |
60 | * behavioral fear response (GO:0001662) | 3.50543017 |
61 | presynaptic membrane assembly (GO:0097105) | 3.48321783 |
62 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.48302616 |
63 | cerebellar granule cell differentiation (GO:0021707) | 3.47881754 |
64 | regulation of dendritic spine development (GO:0060998) | 3.47630916 |
65 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.46856160 |
66 | regulation of neurotransmitter transport (GO:0051588) | 3.46280320 |
67 | regulation of vesicle fusion (GO:0031338) | 3.43719798 |
68 | regulation of female receptivity (GO:0045924) | 3.43627273 |
69 | neurotransmitter uptake (GO:0001504) | 3.42821336 |
70 | long term synaptic depression (GO:0060292) | 3.42294491 |
71 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.41322635 |
72 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.39809194 |
73 | regulation of synapse maturation (GO:0090128) | 3.32321635 |
74 | homocysteine metabolic process (GO:0050667) | 3.27737555 |
75 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.27545221 |
76 | * fear response (GO:0042596) | 3.27209308 |
77 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.25869013 |
78 | gamma-aminobutyric acid transport (GO:0015812) | 3.25086416 |
79 | chemosensory behavior (GO:0007635) | 3.25002146 |
80 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.24864362 |
81 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.23905733 |
82 | regulation of glutamate secretion (GO:0014048) | 3.23555639 |
83 | * learning (GO:0007612) | 3.23281363 |
84 | neuromuscular synaptic transmission (GO:0007274) | 3.22841333 |
85 | female mating behavior (GO:0060180) | 3.22835211 |
86 | neurotransmitter transport (GO:0006836) | 3.22542804 |
87 | vesicle transport along microtubule (GO:0047496) | 3.21606696 |
88 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.20892565 |
89 | acidic amino acid transport (GO:0015800) | 3.20720665 |
90 | startle response (GO:0001964) | 3.19854296 |
91 | axon ensheathment in central nervous system (GO:0032291) | 3.19729929 |
92 | central nervous system myelination (GO:0022010) | 3.19729929 |
93 | synaptic vesicle transport (GO:0048489) | 3.17820748 |
94 | establishment of synaptic vesicle localization (GO:0097480) | 3.17820748 |
95 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.17035246 |
96 | neuromuscular process controlling posture (GO:0050884) | 3.16639648 |
97 | membrane depolarization (GO:0051899) | 3.16469307 |
98 | regulation of neurotransmitter secretion (GO:0046928) | 3.15393294 |
99 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.15348214 |
100 | dendrite morphogenesis (GO:0048813) | 3.15102088 |
101 | potassium ion homeostasis (GO:0055075) | 3.15069474 |
102 | presynaptic membrane organization (GO:0097090) | 3.14856353 |
103 | sodium ion export (GO:0071436) | 3.14147916 |
104 | activation of protein kinase A activity (GO:0034199) | 3.11883165 |
105 | cell communication by electrical coupling (GO:0010644) | 3.10800967 |
106 | dicarboxylic acid transport (GO:0006835) | 3.09051623 |
107 | regulation of synaptic transmission (GO:0050804) | 3.07383291 |
108 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.05962598 |
109 | potassium ion import (GO:0010107) | 3.04474629 |
110 | microtubule nucleation (GO:0007020) | 3.03850881 |
111 | vesicle docking involved in exocytosis (GO:0006904) | 3.02822479 |
112 | neuromuscular process controlling balance (GO:0050885) | 3.00504486 |
113 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.00348441 |
114 | positive regulation of neurotransmitter transport (GO:0051590) | 2.98685552 |
115 | membrane depolarization during action potential (GO:0086010) | 2.98480904 |
116 | organelle transport along microtubule (GO:0072384) | 2.96909224 |
117 | positive regulation of synaptic transmission (GO:0050806) | 2.96348180 |
118 | synapse assembly (GO:0007416) | 2.96321169 |
119 | intraspecies interaction between organisms (GO:0051703) | 2.96048040 |
120 | social behavior (GO:0035176) | 2.96048040 |
121 | * synaptic transmission (GO:0007268) | 2.95427795 |
122 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.95058350 |
123 | regulation of neurotransmitter levels (GO:0001505) | 2.92976343 |
124 | glycosphingolipid biosynthetic process (GO:0006688) | 2.91401860 |
125 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.90684678 |
126 | vesicle docking (GO:0048278) | 2.90017350 |
127 | auditory behavior (GO:0031223) | 2.87746182 |
128 | establishment of mitochondrion localization (GO:0051654) | 2.87534918 |
129 | negative regulation of amino acid transport (GO:0051956) | 2.87251126 |
130 | behavioral response to cocaine (GO:0048148) | 2.86801117 |
131 | L-glutamate transport (GO:0015813) | 2.86306193 |
132 | * innervation (GO:0060384) | 2.85894431 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.52713003 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.04291181 |
3 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.23747810 |
4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.20860904 |
5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.07235147 |
6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.79851952 |
7 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.77745072 |
8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.68256796 |
9 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.67679128 |
10 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.67679128 |
11 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.61647679 |
12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.55991866 |
13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.51782639 |
14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.50153532 |
15 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.49161861 |
16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.49065735 |
17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.45046109 |
18 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.30876321 |
19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.22748221 |
20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.21965560 |
21 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.20981536 |
22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.19904494 |
23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.19842358 |
24 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.18734529 |
25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.04416906 |
26 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.00687995 |
27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.98736712 |
28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.96461803 |
29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.85433432 |
30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.84619243 |
31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.80760815 |
32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.79145292 |
33 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.72071213 |
34 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.71133299 |
35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.68067202 |
36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.66295183 |
37 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.65459391 |
38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.57295501 |
39 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.56251508 |
40 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.47403192 |
41 | FUS_26573619_Chip-Seq_HEK293_Human | 1.47137840 |
42 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.46094799 |
43 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.45997510 |
44 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.45195972 |
45 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44891037 |
46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.43210798 |
47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42997998 |
48 | AR_25329375_ChIP-Seq_VCAP_Human | 1.42598371 |
49 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.41765004 |
50 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.39825133 |
51 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.39024153 |
52 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.35703045 |
53 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.34159434 |
54 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.33684247 |
55 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.32995846 |
56 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.32710566 |
57 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.32367341 |
58 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30531828 |
59 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30006498 |
60 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.30002021 |
61 | VDR_22108803_ChIP-Seq_LS180_Human | 1.29899794 |
62 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25564411 |
63 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.22879390 |
64 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.22733970 |
65 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21767068 |
66 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21462878 |
67 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.21372806 |
68 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.20772186 |
69 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.17590244 |
70 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.17261612 |
71 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16420550 |
72 | AR_19668381_ChIP-Seq_PC3_Human | 1.15497915 |
73 | TP53_16413492_ChIP-PET_HCT116_Human | 1.14555185 |
74 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14239899 |
75 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.12755650 |
76 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12680656 |
77 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11508846 |
78 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11115319 |
79 | TCF4_23295773_ChIP-Seq_U87_Human | 1.10711358 |
80 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.10235042 |
81 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09876637 |
82 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08371432 |
83 | * JUN_21703547_ChIP-Seq_K562_Human | 1.07552119 |
84 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05533533 |
85 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05134046 |
86 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.05055433 |
87 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04980083 |
88 | KDM2B_26808549_Chip-Seq_REH_Human | 1.04598319 |
89 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04237577 |
90 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.03524222 |
91 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03156965 |
92 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02986470 |
93 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.02697453 |
94 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01454098 |
95 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.00699100 |
96 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.99972005 |
97 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99576225 |
98 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.99142235 |
99 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98797586 |
100 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.98785254 |
101 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98682143 |
102 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98682143 |
103 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.97714907 |
104 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.97637231 |
105 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97360262 |
106 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96248709 |
107 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.95072501 |
108 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95062178 |
109 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.94791454 |
110 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.94163991 |
111 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94071952 |
112 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93605738 |
113 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.93348464 |
114 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92527399 |
115 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91925773 |
116 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91569998 |
117 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.91320939 |
118 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.89809827 |
119 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.88093483 |
120 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.87671746 |
121 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.86698079 |
122 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.86634941 |
123 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.85681905 |
124 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.85651613 |
125 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83981438 |
126 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83650573 |
127 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83458738 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 7.25710689 |
2 | MP0003880_abnormal_central_pattern | 5.83869294 |
3 | * MP0003635_abnormal_synaptic_transmissio | 4.33216976 |
4 | MP0004270_analgesia | 3.89969923 |
5 | * MP0002063_abnormal_learning/memory/cond | 3.63241908 |
6 | * MP0009745_abnormal_behavioral_response | 3.46214572 |
7 | MP0002064_seizures | 3.11505328 |
8 | MP0001968_abnormal_touch/_nociception | 3.08085038 |
9 | MP0002572_abnormal_emotion/affect_behav | 2.95068827 |
10 | MP0002736_abnormal_nociception_after | 2.68067584 |
11 | MP0001501_abnormal_sleep_pattern | 2.59883954 |
12 | MP0002735_abnormal_chemical_nociception | 2.57838488 |
13 | MP0002272_abnormal_nervous_system | 2.55631307 |
14 | MP0001440_abnormal_grooming_behavior | 2.53079817 |
15 | MP0009046_muscle_twitch | 2.48538192 |
16 | MP0002734_abnormal_mechanical_nocicepti | 2.43388150 |
17 | MP0001486_abnormal_startle_reflex | 2.39959606 |
18 | MP0005423_abnormal_somatic_nervous | 2.36880447 |
19 | MP0003329_amyloid_beta_deposits | 2.25475252 |
20 | MP0000778_abnormal_nervous_system | 2.12159169 |
21 | MP0006276_abnormal_autonomic_nervous | 1.98498294 |
22 | MP0002733_abnormal_thermal_nociception | 1.94517815 |
23 | MP0009780_abnormal_chondrocyte_physiolo | 1.93664779 |
24 | MP0002067_abnormal_sensory_capabilities | 1.92315434 |
25 | MP0001970_abnormal_pain_threshold | 1.85187086 |
26 | * MP0002184_abnormal_innervation | 1.76103830 |
27 | MP0004811_abnormal_neuron_physiology | 1.70083523 |
28 | MP0002557_abnormal_social/conspecific_i | 1.68271545 |
29 | MP0005386_behavior/neurological_phenoty | 1.66992685 |
30 | MP0004924_abnormal_behavior | 1.66992685 |
31 | MP0002909_abnormal_adrenal_gland | 1.59789603 |
32 | MP0002822_catalepsy | 1.58348558 |
33 | MP0004858_abnormal_nervous_system | 1.54877887 |
34 | MP0000955_abnormal_spinal_cord | 1.53275814 |
35 | MP0001529_abnormal_vocalization | 1.52062312 |
36 | MP0008569_lethality_at_weaning | 1.50728599 |
37 | MP0004147_increased_porphyrin_level | 1.49158216 |
38 | MP0003879_abnormal_hair_cell | 1.44687499 |
39 | MP0003787_abnormal_imprinting | 1.44003203 |
40 | MP0002837_dystrophic_cardiac_calcinosis | 1.42780623 |
41 | MP0003183_abnormal_peptide_metabolism | 1.38707277 |
42 | * MP0002882_abnormal_neuron_morphology | 1.38267874 |
43 | * MP0002066_abnormal_motor_capabilities/c | 1.37284784 |
44 | MP0001905_abnormal_dopamine_level | 1.34303632 |
45 | MP0004885_abnormal_endolymph | 1.34240580 |
46 | MP0001984_abnormal_olfaction | 1.29704757 |
47 | MP0005670_abnormal_white_adipose | 1.23107698 |
48 | MP0001188_hyperpigmentation | 1.22275528 |
49 | MP0008877_abnormal_DNA_methylation | 1.20379305 |
50 | MP0003633_abnormal_nervous_system | 1.19473819 |
51 | MP0005646_abnormal_pituitary_gland | 1.19221766 |
52 | MP0005645_abnormal_hypothalamus_physiol | 1.17457550 |
53 | MP0001502_abnormal_circadian_rhythm | 1.16906102 |
54 | * MP0002152_abnormal_brain_morphology | 1.10429357 |
55 | MP0000604_amyloidosis | 1.09730972 |
56 | MP0004142_abnormal_muscle_tone | 1.09600499 |
57 | MP0003631_nervous_system_phenotype | 1.06814165 |
58 | MP0010386_abnormal_urinary_bladder | 1.06690442 |
59 | MP0004510_myositis | 1.01518034 |
60 | MP0004484_altered_response_of | 0.96513898 |
61 | MP0003121_genomic_imprinting | 0.96402092 |
62 | MP0004145_abnormal_muscle_electrophysio | 0.95471112 |
63 | MP0000751_myopathy | 0.95129759 |
64 | MP0003705_abnormal_hypodermis_morpholog | 0.92586578 |
65 | MP0003122_maternal_imprinting | 0.91201762 |
66 | MP0005551_abnormal_eye_electrophysiolog | 0.89645090 |
67 | MP0002876_abnormal_thyroid_physiology | 0.88896592 |
68 | * MP0002069_abnormal_eating/drinking_beha | 0.88764947 |
69 | MP0005535_abnormal_body_temperature | 0.87727221 |
70 | * MP0002229_neurodegeneration | 0.82501929 |
71 | MP0005409_darkened_coat_color | 0.82233426 |
72 | MP0008874_decreased_physiological_sensi | 0.81759698 |
73 | MP0004085_abnormal_heartbeat | 0.81374708 |
74 | MP0003075_altered_response_to | 0.80483549 |
75 | MP0004133_heterotaxia | 0.80006399 |
76 | MP0006292_abnormal_olfactory_placode | 0.77139772 |
77 | MP0004215_abnormal_myocardial_fiber | 0.76914095 |
78 | MP0003632_abnormal_nervous_system | 0.76849252 |
79 | MP0003634_abnormal_glial_cell | 0.76525082 |
80 | MP0002638_abnormal_pupillary_reflex | 0.76053688 |
81 | MP0004742_abnormal_vestibular_system | 0.75383604 |
82 | * MP0001963_abnormal_hearing_physiology | 0.74785039 |
83 | MP0005394_taste/olfaction_phenotype | 0.74784757 |
84 | MP0005499_abnormal_olfactory_system | 0.74784757 |
85 | MP0008872_abnormal_physiological_respon | 0.74684901 |
86 | MP0008995_early_reproductive_senescence | 0.73324413 |
87 | * MP0002752_abnormal_somatic_nervous | 0.71877420 |
88 | MP0000631_abnormal_neuroendocrine_gland | 0.70591576 |
89 | MP0001664_abnormal_digestion | 0.70312224 |
90 | MP0001177_atelectasis | 0.70305804 |
91 | MP0002234_abnormal_pharynx_morphology | 0.68540075 |
92 | MP0000579_abnormal_nail_morphology | 0.67096210 |
93 | * MP0000026_abnormal_inner_ear | 0.65135887 |
94 | MP0005187_abnormal_penis_morphology | 0.64572471 |
95 | MP0003861_abnormal_nervous_system | 0.61245362 |
96 | MP0003123_paternal_imprinting | 0.60883454 |
97 | MP0003890_abnormal_embryonic-extraembry | 0.60577818 |
98 | MP0009672_abnormal_birth_weight | 0.60373890 |
99 | MP0002090_abnormal_vision | 0.60145346 |
100 | MP0005623_abnormal_meninges_morphology | 0.59866902 |
101 | MP0010234_abnormal_vibrissa_follicle | 0.59652681 |
102 | MP0002653_abnormal_ependyma_morphology | 0.59549761 |
103 | MP0003137_abnormal_impulse_conducting | 0.59541181 |
104 | MP0008961_abnormal_basal_metabolism | 0.59521581 |
105 | MP0000569_abnormal_digit_pigmentation | 0.58716478 |
106 | MP0004130_abnormal_muscle_cell | 0.58649376 |
107 | MP0000920_abnormal_myelination | 0.58593186 |
108 | MP0000013_abnormal_adipose_tissue | 0.58538905 |
109 | MP0001986_abnormal_taste_sensitivity | 0.57484542 |
110 | MP0000534_abnormal_ureter_morphology | 0.56138701 |
111 | MP0009379_abnormal_foot_pigmentation | 0.55555506 |
112 | MP0004043_abnormal_pH_regulation | 0.55464311 |
113 | MP0004233_abnormal_muscle_weight | 0.54839003 |
114 | MP0001485_abnormal_pinna_reflex | 0.54783690 |
115 | MP0003941_abnormal_skin_development | 0.53925830 |
116 | MP0010769_abnormal_survival | 0.52537181 |
117 | MP0001765_abnormal_ion_homeostasis | 0.52405197 |
118 | MP0003690_abnormal_glial_cell | 0.51900086 |
119 | MP0005595_abnormal_vascular_smooth | 0.51556931 |
120 | MP0010768_mortality/aging | 0.51263207 |
121 | MP0010770_preweaning_lethality | 0.51008988 |
122 | MP0002082_postnatal_lethality | 0.51008988 |
123 | MP0003938_abnormal_ear_development | 0.50880398 |
124 | MP0001346_abnormal_lacrimal_gland | 0.50561495 |
125 | MP0003956_abnormal_body_size | 0.48835521 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 8.24060620 |
2 | Myokymia (HP:0002411) | 6.44069042 |
3 | Focal seizures (HP:0007359) | 5.89247877 |
4 | Visual hallucinations (HP:0002367) | 5.71753334 |
5 | Epileptic encephalopathy (HP:0200134) | 5.15682364 |
6 | Atonic seizures (HP:0010819) | 4.86564643 |
7 | Absence seizures (HP:0002121) | 4.68966009 |
8 | Febrile seizures (HP:0002373) | 4.46608244 |
9 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.46206821 |
10 | Abnormality of alanine metabolism (HP:0010916) | 4.46206821 |
11 | Hyperalaninemia (HP:0003348) | 4.46206821 |
12 | Hyperventilation (HP:0002883) | 4.36602386 |
13 | Dialeptic seizures (HP:0011146) | 4.34711656 |
14 | Progressive cerebellar ataxia (HP:0002073) | 4.27765982 |
15 | Cerebral inclusion bodies (HP:0100314) | 4.24157433 |
16 | Supranuclear gaze palsy (HP:0000605) | 4.19366369 |
17 | Generalized tonic-clonic seizures (HP:0002069) | 4.03952053 |
18 | Neurofibrillary tangles (HP:0002185) | 3.70873039 |
19 | Broad-based gait (HP:0002136) | 3.69229659 |
20 | Cerebral hypomyelination (HP:0006808) | 3.65482206 |
21 | Amblyopia (HP:0000646) | 3.59637706 |
22 | Drooling (HP:0002307) | 3.43742292 |
23 | Excessive salivation (HP:0003781) | 3.43742292 |
24 | Mutism (HP:0002300) | 3.29671922 |
25 | Abnormality of binocular vision (HP:0011514) | 3.24824535 |
26 | Diplopia (HP:0000651) | 3.24824535 |
27 | Action tremor (HP:0002345) | 3.20841785 |
28 | Abnormality of the lower motor neuron (HP:0002366) | 3.19233578 |
29 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.18881540 |
30 | Limb dystonia (HP:0002451) | 3.15829198 |
31 | Dysmetria (HP:0001310) | 3.12868968 |
32 | Poor eye contact (HP:0000817) | 3.05901367 |
33 | Anxiety (HP:0000739) | 3.04202139 |
34 | Epileptiform EEG discharges (HP:0011182) | 2.96891218 |
35 | Depression (HP:0000716) | 2.96797515 |
36 | Clonus (HP:0002169) | 2.96246618 |
37 | Truncal ataxia (HP:0002078) | 2.95792236 |
38 | Hemiparesis (HP:0001269) | 2.95235134 |
39 | Dysdiadochokinesis (HP:0002075) | 2.86532017 |
40 | Amyotrophic lateral sclerosis (HP:0007354) | 2.85125210 |
41 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.84523005 |
42 | Gaze-evoked nystagmus (HP:0000640) | 2.82655792 |
43 | Delusions (HP:0000746) | 2.79372230 |
44 | Absent speech (HP:0001344) | 2.76465641 |
45 | Abnormal eating behavior (HP:0100738) | 2.74899111 |
46 | Impaired social interactions (HP:0000735) | 2.73064267 |
47 | Abnormal social behavior (HP:0012433) | 2.73064267 |
48 | Heterochromia iridis (HP:0001100) | 2.70865949 |
49 | Abnormality of the labia minora (HP:0012880) | 2.67461556 |
50 | EEG with generalized epileptiform discharges (HP:0011198) | 2.63164147 |
51 | Insidious onset (HP:0003587) | 2.63132930 |
52 | Termporal pattern (HP:0011008) | 2.63132930 |
53 | Progressive inability to walk (HP:0002505) | 2.62921199 |
54 | Birth length less than 3rd percentile (HP:0003561) | 2.60402126 |
55 | Genetic anticipation (HP:0003743) | 2.60264316 |
56 | Impaired smooth pursuit (HP:0007772) | 2.58413804 |
57 | Postural instability (HP:0002172) | 2.57095223 |
58 | Ankle clonus (HP:0011448) | 2.47894963 |
59 | Papilledema (HP:0001085) | 2.46548147 |
60 | Sleep apnea (HP:0010535) | 2.46528365 |
61 | Abnormality of the corticospinal tract (HP:0002492) | 2.46150479 |
62 | Urinary urgency (HP:0000012) | 2.44759280 |
63 | Bradykinesia (HP:0002067) | 2.43924841 |
64 | Constricted visual fields (HP:0001133) | 2.42970959 |
65 | Hypsarrhythmia (HP:0002521) | 2.41197794 |
66 | Abnormality of salivation (HP:0100755) | 2.37590230 |
67 | Stereotypic behavior (HP:0000733) | 2.37262813 |
68 | Inability to walk (HP:0002540) | 2.36893297 |
69 | Generalized myoclonic seizures (HP:0002123) | 2.35612116 |
70 | Hydroureter (HP:0000072) | 2.35250059 |
71 | White forelock (HP:0002211) | 2.33435550 |
72 | Fetal akinesia sequence (HP:0001989) | 2.29469459 |
73 | Spastic gait (HP:0002064) | 2.25108234 |
74 | Polyphagia (HP:0002591) | 2.24010909 |
75 | Inappropriate behavior (HP:0000719) | 2.21157837 |
76 | Scanning speech (HP:0002168) | 2.20532337 |
77 | Protruding tongue (HP:0010808) | 2.20175657 |
78 | Apathy (HP:0000741) | 2.19310377 |
79 | Dyskinesia (HP:0100660) | 2.19074143 |
80 | Megalencephaly (HP:0001355) | 2.18772820 |
81 | Congenital sensorineural hearing impairment (HP:0008527) | 2.14925854 |
82 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.14572367 |
83 | Rapidly progressive (HP:0003678) | 2.11020692 |
84 | Impaired vibratory sensation (HP:0002495) | 2.09397960 |
85 | Focal dystonia (HP:0004373) | 2.08056347 |
86 | Annular pancreas (HP:0001734) | 2.06832663 |
87 | Status epilepticus (HP:0002133) | 2.06529483 |
88 | Torticollis (HP:0000473) | 2.06097211 |
89 | Patchy hypopigmentation of hair (HP:0011365) | 2.04628154 |
90 | Poor speech (HP:0002465) | 2.04567477 |
91 | Tetraplegia (HP:0002445) | 2.03944293 |
92 | Lower limb muscle weakness (HP:0007340) | 2.01971822 |
93 | Poor suck (HP:0002033) | 2.01678350 |
94 | Psychosis (HP:0000709) | 2.01262633 |
95 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.00218381 |
96 | Thickened helices (HP:0000391) | 1.99909870 |
97 | Morphological abnormality of the inner ear (HP:0011390) | 1.98180192 |
98 | Abnormality of serum amino acid levels (HP:0003112) | 1.97213604 |
99 | CNS hypomyelination (HP:0003429) | 1.96940284 |
100 | Split foot (HP:0001839) | 1.96793409 |
101 | Intention tremor (HP:0002080) | 1.96549559 |
102 | Retinal dysplasia (HP:0007973) | 1.95819615 |
103 | Homocystinuria (HP:0002156) | 1.95815549 |
104 | Abnormality of homocysteine metabolism (HP:0010919) | 1.95815549 |
105 | Blue irides (HP:0000635) | 1.94987990 |
106 | Abnormality of cochlea (HP:0000375) | 1.94314752 |
107 | Incomplete penetrance (HP:0003829) | 1.92648694 |
108 | Akinesia (HP:0002304) | 1.90622287 |
109 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.90561221 |
110 | Single umbilical artery (HP:0001195) | 1.90561221 |
111 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.90561221 |
112 | Diminished motivation (HP:0000745) | 1.90283937 |
113 | Obstructive sleep apnea (HP:0002870) | 1.89345813 |
114 | Urinary incontinence (HP:0000020) | 1.87888404 |
115 | Oligomenorrhea (HP:0000876) | 1.84749908 |
116 | Agnosia (HP:0010524) | 1.84708767 |
117 | Insomnia (HP:0100785) | 1.84180290 |
118 | Neuronal loss in central nervous system (HP:0002529) | 1.83672086 |
119 | Type II lissencephaly (HP:0007260) | 1.83177863 |
120 | Lower limb amyotrophy (HP:0007210) | 1.82300767 |
121 | Gait ataxia (HP:0002066) | 1.81788838 |
122 | Aqueductal stenosis (HP:0002410) | 1.81612769 |
123 | Hemiplegia (HP:0002301) | 1.80773831 |
124 | Esophageal varix (HP:0002040) | 1.77845557 |
125 | Widely spaced teeth (HP:0000687) | 1.77709980 |
126 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.76996180 |
127 | Agitation (HP:0000713) | 1.76695082 |
128 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.76633868 |
129 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.76633868 |
130 | Lower limb asymmetry (HP:0100559) | 1.75587535 |
131 | Ventricular fibrillation (HP:0001663) | 1.75244341 |
132 | Gait imbalance (HP:0002141) | 1.73304727 |
133 | Anosmia (HP:0000458) | 1.72789092 |
134 | Craniofacial dystonia (HP:0012179) | 1.72417855 |
135 | Testicular atrophy (HP:0000029) | 1.72363927 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 5.15213663 |
2 | NTRK3 | 4.74210066 |
3 | MAP3K9 | 3.62997499 |
4 | MARK1 | 3.47219795 |
5 | RIPK4 | 3.28038849 |
6 | MAP3K4 | 2.95448977 |
7 | MINK1 | 2.85298987 |
8 | MAP2K7 | 2.53354004 |
9 | MAP3K12 | 2.36972119 |
10 | KSR2 | 2.10566964 |
11 | DAPK2 | 2.02407832 |
12 | PLK2 | 2.01568044 |
13 | CASK | 1.94089061 |
14 | KSR1 | 1.93912352 |
15 | MAP2K4 | 1.91592523 |
16 | PNCK | 1.89227140 |
17 | DAPK1 | 1.84458344 |
18 | PAK6 | 1.83127012 |
19 | NTRK2 | 1.74714149 |
20 | ARAF | 1.64021296 |
21 | PTK2B | 1.56874890 |
22 | GRK5 | 1.56359228 |
23 | PRKD3 | 1.54378518 |
24 | SIK2 | 1.51520322 |
25 | BMPR2 | 1.51163869 |
26 | CDK5 | 1.48555521 |
27 | NTRK1 | 1.47476418 |
28 | CCNB1 | 1.44433391 |
29 | NME1 | 1.42614958 |
30 | TNIK | 1.41694506 |
31 | MAP3K13 | 1.38533400 |
32 | PRKCG | 1.35473071 |
33 | FES | 1.30759531 |
34 | MAPK13 | 1.30745405 |
35 | PRPF4B | 1.28821677 |
36 | CAMK2A | 1.25848558 |
37 | CAMKK1 | 1.21978509 |
38 | CAMK2B | 1.21712872 |
39 | FGR | 1.18360164 |
40 | NEK6 | 1.13742508 |
41 | CDK19 | 1.12684072 |
42 | RAF1 | 1.08853716 |
43 | ALK | 1.06186094 |
44 | LATS2 | 1.06044306 |
45 | STK38 | 1.04899264 |
46 | BRSK1 | 0.99448870 |
47 | MAP3K2 | 0.97116195 |
48 | TSSK6 | 0.92998479 |
49 | DYRK2 | 0.90455521 |
50 | DYRK1A | 0.89529976 |
51 | CDK18 | 0.86439910 |
52 | SGK3 | 0.86184928 |
53 | PHKG1 | 0.86030024 |
54 | PHKG2 | 0.86030024 |
55 | CDK14 | 0.84960311 |
56 | CDK15 | 0.83460425 |
57 | CAMK1 | 0.76622504 |
58 | PAK3 | 0.75958575 |
59 | UHMK1 | 0.75695368 |
60 | TYRO3 | 0.73763607 |
61 | PLK3 | 0.73303371 |
62 | CDK11A | 0.72410229 |
63 | FER | 0.68625907 |
64 | CDK9 | 0.67921937 |
65 | STK11 | 0.66858531 |
66 | GRK6 | 0.65604067 |
67 | MAPKAPK5 | 0.64524712 |
68 | SGK1 | 0.64495448 |
69 | DAPK3 | 0.64029042 |
70 | ACVR1B | 0.63621640 |
71 | MAP3K6 | 0.63163877 |
72 | OXSR1 | 0.60749342 |
73 | CSNK1G2 | 0.60639641 |
74 | RET | 0.59437703 |
75 | LIMK1 | 0.59396249 |
76 | MARK2 | 0.58832822 |
77 | WNK3 | 0.57357845 |
78 | PRKCE | 0.57223508 |
79 | CAMK2D | 0.56232147 |
80 | PRKCZ | 0.55704965 |
81 | PDK1 | 0.53286555 |
82 | CSNK1A1 | 0.52084815 |
83 | MAP3K7 | 0.49400725 |
84 | SGK223 | 0.48788463 |
85 | SGK494 | 0.48788463 |
86 | MAP3K11 | 0.48200439 |
87 | CSNK1G3 | 0.47962887 |
88 | MAP3K3 | 0.46750199 |
89 | PDPK1 | 0.46738547 |
90 | FYN | 0.46360335 |
91 | DMPK | 0.44835161 |
92 | GRK7 | 0.44467719 |
93 | MAPK12 | 0.44083614 |
94 | CSNK1G1 | 0.43555904 |
95 | MAP3K1 | 0.43141057 |
96 | PINK1 | 0.42771272 |
97 | MAP2K1 | 0.41837242 |
98 | CAMK4 | 0.41454858 |
99 | MKNK2 | 0.41072663 |
100 | ROCK2 | 0.40888789 |
101 | CAMK2G | 0.40583383 |
102 | BRAF | 0.40511468 |
103 | MAPK10 | 0.38606729 |
104 | PRKCH | 0.37589026 |
105 | RPS6KA3 | 0.37499065 |
106 | BCR | 0.37272388 |
107 | CSNK1A1L | 0.37129570 |
108 | CAMKK2 | 0.35367183 |
109 | TNK2 | 0.34642381 |
110 | ADRBK1 | 0.34033695 |
111 | BUB1 | 0.33530335 |
112 | SGK2 | 0.33376549 |
113 | TRIM28 | 0.32142064 |
114 | MOS | 0.31854688 |
115 | CSNK1E | 0.31784372 |
116 | RPS6KB1 | 0.30471139 |
117 | MAP2K3 | 0.29580484 |
118 | LMTK2 | 0.29440207 |
119 | SYK | 0.29322072 |
120 | PRKCA | 0.28741294 |
121 | PRKCQ | 0.28719504 |
122 | CDC7 | 0.28312594 |
123 | PKN1 | 0.27844296 |
124 | PRKCB | 0.27568035 |
125 | MUSK | 0.27265683 |
126 | TAOK1 | 0.27158038 |
127 | PRKACA | 0.26956248 |
128 | SIK3 | 0.26371366 |
129 | AKT3 | 0.26142135 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Nicotine addiction_Homo sapiens_hsa05033 | 4.07625276 |
2 | Long-term potentiation_Homo sapiens_hsa04720 | 3.22953578 |
3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.87528316 |
4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.86026909 |
5 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.83172025 |
6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.76075772 |
7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.72876620 |
8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.51347926 |
9 | * GABAergic synapse_Homo sapiens_hsa04727 | 2.48660167 |
10 | Salivary secretion_Homo sapiens_hsa04970 | 2.38517515 |
11 | * Morphine addiction_Homo sapiens_hsa05032 | 2.36437960 |
12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.28316798 |
13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.26948029 |
14 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.09021286 |
15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.93063523 |
16 | Renin secretion_Homo sapiens_hsa04924 | 1.91604692 |
17 | Insulin secretion_Homo sapiens_hsa04911 | 1.89328562 |
18 | Long-term depression_Homo sapiens_hsa04730 | 1.89290483 |
19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.86003695 |
20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.82045957 |
21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.81879894 |
22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.79597891 |
23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.77151886 |
24 | * Taste transduction_Homo sapiens_hsa04742 | 1.71520273 |
25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.65333196 |
26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.64503653 |
27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.64248412 |
28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.59391108 |
29 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.56276665 |
30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.55246211 |
31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.40237667 |
32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.38198389 |
33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.38176696 |
34 | Gap junction_Homo sapiens_hsa04540 | 1.36355036 |
35 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.33140061 |
36 | Axon guidance_Homo sapiens_hsa04360 | 1.32595040 |
37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.31120383 |
38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.23081055 |
39 | Glioma_Homo sapiens_hsa05214 | 1.20417096 |
40 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16762226 |
41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.16070892 |
42 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.11784013 |
43 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.11535843 |
44 | Melanogenesis_Homo sapiens_hsa04916 | 1.11314444 |
45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.11050092 |
46 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.10961109 |
47 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.10777091 |
48 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.02499317 |
49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97039830 |
50 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.97037123 |
51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.95961749 |
52 | Alzheimers disease_Homo sapiens_hsa05010 | 0.94571481 |
53 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.93724099 |
54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.93076217 |
55 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.91932085 |
56 | Phototransduction_Homo sapiens_hsa04744 | 0.89979412 |
57 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.89230007 |
58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87867225 |
59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.85950358 |
60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.85352368 |
61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82226939 |
62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76194869 |
63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.75011367 |
64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73977266 |
65 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.73851625 |
66 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73070375 |
67 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72524271 |
68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72412184 |
69 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.70799528 |
70 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.70740617 |
71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68355790 |
72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.67300078 |
73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65401750 |
74 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.64327627 |
75 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61710759 |
76 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60656418 |
77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58931673 |
78 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55921839 |
79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54538870 |
80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52412280 |
81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52046263 |
82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50470045 |
83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50195583 |
84 | Prion diseases_Homo sapiens_hsa05020 | 0.48125410 |
85 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.44242870 |
86 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.42612544 |
87 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.42056083 |
88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41774917 |
89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40623447 |
90 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.40336335 |
91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40165908 |
92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39829671 |
93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39658997 |
94 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.39079998 |
95 | Bile secretion_Homo sapiens_hsa04976 | 0.38712919 |
96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37742007 |
97 | Parkinsons disease_Homo sapiens_hsa05012 | 0.37675770 |
98 | Alcoholism_Homo sapiens_hsa05034 | 0.37615322 |
99 | Huntingtons disease_Homo sapiens_hsa05016 | 0.37021267 |
100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.35710575 |
101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35446599 |
102 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34115782 |
103 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.32093521 |
104 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.31915076 |
105 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31312836 |
106 | Endocytosis_Homo sapiens_hsa04144 | 0.30667159 |
107 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.30583490 |
108 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.30424784 |
109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28703776 |
110 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.27796500 |
111 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26952724 |
112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26400671 |
113 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.26261691 |
114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.24874138 |
115 | Mineral absorption_Homo sapiens_hsa04978 | 0.24850636 |
116 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.24823190 |
117 | Tight junction_Homo sapiens_hsa04530 | 0.24507418 |
118 | Endometrial cancer_Homo sapiens_hsa05213 | 0.24401818 |
119 | Circadian rhythm_Homo sapiens_hsa04710 | 0.24221974 |
120 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24146985 |
121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.23891371 |
122 | Colorectal cancer_Homo sapiens_hsa05210 | 0.23579450 |
123 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.23447194 |
124 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.23385917 |
125 | Galactose metabolism_Homo sapiens_hsa00052 | 0.22768887 |
126 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.22161962 |
127 | Carbon metabolism_Homo sapiens_hsa01200 | 0.18614627 |